U.S. Pharmaceutical Contract Manufacturing Market Report 2022: Increasing Drug Discovery and Manufacturing Outsourcing to Drive Growth – ResearchAndMarkets.com | Nation/World


The “U.S. Pharmaceutical Contract Manufacturing Market Research and Forecast 2022-2028” report has been added to ResearchAndMarkets.comoffer.

Pharmaceutical contract manufacturing in the United States is growing at a considerable CAGR of 4.8% during the forecast period. Growing demand for innovative drugs and medical devices is one of the major factors affecting and driving the market.

Increase in drug discovery and outsourcing of manufacturing along with patent cliffs are also estimated to be the major factors contributing significantly to the growth of the market. However, rising logistics costs along with stringent government rules and regulations are some of the major factors hindering the growth of pharmaceutical contract manufacturing in the United States.

Moreover, offering effective services at low cost is one of the key factors that create opportunities for the market. New product launches in the market are likely to drive the growth of the global wheelchair market. For example, in December 2019, Thermo Fisher Scientific Inc., which is considered one of the scientific serving companies, expanded its contract development and manufacturing organization (CDMO) to Lexington, Mass.

The company has invested approximately $90 million in a 50,000 square foot facility that will offer and support the development, testing and manufacturing of viral vectors. In addition, through this investment, the company will create approximately 200 jobs while offering a range of services by accelerating the commercialization of new therapies.

The report covers

  • Market value data analysis of 2020 and forecast till 2027.
  • Annualized market revenue ($millions) for each market segment.
  • Country analysis of major geographic regions.
  • Major companies operating in the contract manufacturing of pharmaceutical products in the United States. Based on data availability, information related to new product launches and relevant news is also available in the report.
  • Analysis of business strategies by identifying key market segments positioned for strong growth in the future.
  • Analysis of market entry and expansion strategies.
  • Competitive strategies by identifying “who is where in the market”.

Main topics covered:

1. Summary of the report

2. Overview and Market Overview

3. Competitive Landscape

4. Market drivers

5. Market segmentation

5.1. US Pharmaceutical Contract Manufacturing Market by Category

5.1.1. Drugs of human origin

5.1.2. Medicines of animal origin

5.2. US Pharmaceutical Contract Manufacturing Market by Product

5.2.1. Over-the-counter (OTC) drugs

5.2.2. Active Pharmaceutical Ingredients (API)

5.2.3. Finished dosage formulation

5.2.4. Other

5.3. Contract Manufacturing of Pharmaceuticals in the United States by Services

5.3.1. Manufacturing Services

5.3.2. Non-clinical services

5.3.3. Research and development

6. Company Profiles

Companies cited

  • AbbVie Inc.
  • Ajinomoto Bio-Pharma
  • Catalent, Inc.
  • Cardinal Health.
  • Denison Pharmaceuticals
  • Dravon Medical Inc.
  • East-West Manufacturing
  • HISUN USA, Inc.
  • HTI plastics
  • Hikma Pharmaceuticals PLC
  • Lonza capsules and health ingredients
  • McGuff Pharmaceuticals, Inc.
  • Medix Biochemistry
  • Nextphase Medical Devices, LLC.
  • Nutra Solutions United States
  • Nutrafill, LLC
  • Pfizer Inc.
  • Phoenix Deventures Inc.
  • SMC Ltd.
  • Stason Pharmaceuticals
  • Superior Supplement Manufacturing
  • Thermo Fisher Scientific Inc.
  • West Pharmaceutical Services, Inc.
  • Zoetis

For more information on this report, visit https://www.researchandmarkets.com/r/o04xyy

Show source version on businesswire.com:https://www.businesswire.com/news/home/20220923005372/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Officer

[email protected]

For EST business hours, call 1-917-300-0470

For the United States and Canada, call toll-free 1-800-526-8630

For GMT office hours call +353-1-416-8900



SOURCE: Research and Markets

Copyright BusinessWire 2022.

PUBLISHED: 09/23/2022 10:11 a.m. / DISK: 09/23/2022 10:12 a.m.


Copyright BusinessWire 2022.